.


:




:

































 

 

 

 


- 30% !




- ? , , " ". .

: ( ()); (), ); , , - , . .- . . : !

( : Common adverse drug reactions (ADRs) associated with metoclopramide therapy include: restlessness, drowsiness, dizziness, lassitude, and or dystonic reactions. Infrequent ADRs include: headache, extrapyramidal effects such as oculogyric crisis, hypertension, hypotension, hyperprolactinaemia leading to galactorrhoea, diarrhoea, constipation, and or depression. Rare but serious ADRs associated with metoclopramide therapy include: agranulocytosis, supraventricular tachycardia, hyperaldosteronism, neuroleptic malignant syndrome and/or tardive dyskinesia.[6] Dystonic reactions are usually treated with benztropine or procyclidine. The risk of extrapyramidal effects is increased in young adults (<20 years) and children, ". -" "*. * http://en.wikipedia.org/wiki/Reglan

, , - ? , . - . ? - . ! - . , "" ? . , . , - http://en.wikipedia.org/wiki/File:Dollarnote_siegel_hq.jpg, . - , , . . , , ## http://www.cchrint.org/2010/03/15/pharma-backed-australian-o

http://www.cchrint.org/2010/03/15/pharma-backed-australian-o

. :

: " . . , 2 5 1999 2007 - ! - ? , , . http://www.alternet.org/drugs/146551 ", , , Vera Hassner Sharav, president of the Alliance for Human Research Protection, in a February 26, 2010 InfoMail".

, - - . - - -- - , , - , , !

* " ? * http://en.wikipedia.org/wiki/File:Dollarnote_siegel_hq.jpg

: , . ( . ). : , , , , .

! , , " "; " -" , , , .

1: . - . , , - .

, , . - - , ; . - - ; "", .





:


: 2018-11-12; !; : 126 |


:

:

. .
==> ...

1720 - | 1651 -


© 2015-2024 lektsii.org - -

: 0.011 .